ICR Healthcare Conscience

Rebranding ICR Healthcare

You may notice we look a little different today. We're thrilled to unveil our new unified global identity: ICR Healthcare. This is the final unification of what’s been nearly a decade of collaboration, growth, and a shared vision for the future of healthcare communications.

Opening Doors: The ICR Healthcare Internship Programme

At ICR Healthcare, our internship programme is a gateway to a career in healthcare communications for young talents from diverse backgrounds. We believe that incorporating varied perspectives are crucial for innovation and success in our sector.

Guiding Clients Through Financial Results: Our Approach

As we approach the end of the earnings season, ICR Healthcare provides a short guide to how we help public companies navigate these important milestones on the road to success.

Diversity Driving Success at ICR Consilium

In an industry where we are navigating intricate regulatory landscapes and communicating complex scientific advancements to a wide range of audiences, adaptability and being able to see all the angles on a problem are paramount. At ICR Consilium, we believe that diversity, in its broadest sense, is the key to delivering an unparalleled service to our clients in the UK and internationally.

Using Social Media for Maximum Impact at Scientific and Investor Conferences

Social media has become an indispensable tool for healthcare companies attending scientific and industry conferences. When used strategically, platforms like LinkedIn can significantly enhance your profile and presence, expand your network among scientific peers, investors and the media, and maximise the value you derive from the event, whether it be virtual or in-person. We have laid out below a few tips on how to harness the power of social media before, during, and after your next conference.

The New EU General Pharmaceutical Legislation: is Europe’s innovation at risk?

NYSE's Roadmap to Wall Street – Managing communications and investor engagement for a US listing, by a CFO who has done it many times

The cautious optimism that we have been talking about all year is still with us. Companies may not be racing to the IPO market yet, but many are considering it and the US remains the most attractive prospect. Several European companies attended the NYSE’s “Roadmap to Wall Street” event in London last month, at which the New York Stock Exchange, and advisers from the legal, financial, communications and investor relations worlds, led sessions to share their experience on how to prepare for a US listing.

Q&A with Mandeep Sehmi, Head of Business Development at Scancell

The American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago from 31 May to 4 June 2024, is one of the most prominent and highly regarded events in the oncology calendar. This year’s event will contain over 200 presentations by leading scientists and companies discussing the latest progress in cancer research and treatment. We asked Dr Mandeep Sehmi, Head of Business Development at Scancell, one of the companies presenting, what excites her about this year’s event.

Clinical Trials Day

Clinical Trials Day (May 20th) is an opportunity to celebrate the central role that clinical trials play in healthcare and to acknowledge the hard work of researchers, healthcare professionals and volunteers.

Lazard T500 Conference

Lazard’s T500 conference, held in London from May 7-9, has become a key talking shop for Europe’s venture and scale-up ecosystem, bringing together venture-backed companies from healthcare, tech and fintech to meet investors and advisers. On the first sunny day after the wettest spring in London for years, entrepreneurs and financiers stood blinking on the sun-drenched terrace just around the corner from the Savoy Hotel overlooking the Thames, clutching coffee and the mood was palpably upbeat.